Anne Samuel
Stock Analyst at JP Morgan
(1.82)
# 3,174
Out of 5,182 analysts
67
Total ratings
50%
Success rate
-3.01%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $3.62 | +93.37% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $81.18 | +55.21% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $158.49 | +82.98% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $18.38 | +36.02% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $24.57 | +144.20% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $158.98 | +11.33% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $45.51 | -20.90% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $9.42 | +197.24% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $26.83 | -21.73% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.34 | +873.78% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $25.23 | +7.02% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.01 | +395.05% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $3.62
Upside: +93.37%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $81.18
Upside: +55.21%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $158.49
Upside: +82.98%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $18.38
Upside: +36.02%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $24.57
Upside: +144.20%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $158.98
Upside: +11.33%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $45.51
Upside: -20.90%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $9.42
Upside: +197.24%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $26.83
Upside: -21.73%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.34
Upside: +873.78%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $25.23
Upside: +7.02%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.01
Upside: +395.05%